Introduction {#s1}
============

In turbulent systems such as the oro-gastro-intestinal tract, adaptation to local niches requires microbial adherence properties to match host receptors and thereby stabilize microbial colonization or infection. H. pylori achieved this goal by developing the BabA and SabA adhesins, which bind to the host fucosylated blood group (bg) ABO antigens (denoted the ABH antigens) and sialylated Lewis antigens, respectively \[[@ppat-0040002-b001]--[@ppat-0040002-b005]\]. These adhesins are relevant to H. pylori pathogenicity since BabA-positive strains are frequently present in both peptic ulceration and gastric cancer \[[@ppat-0040002-b005]--[@ppat-0040002-b008]\]. H. pylori infection and associated gastritis induce expression of mucosal sialylated receptors for the SabA adhesin that also attract peripheral neutrophils to local areas of inflammation \[[@ppat-0040002-b002],[@ppat-0040002-b009]\]. In turn, H. pylori SabA adhesin acts as a "selectin-mimic" in mediating binding to both sialylated epithelium and to neutrophils \[[@ppat-0040002-b002],[@ppat-0040002-b010]\].

The A, B, and H antigens are complex fucosylated carbohydrates expressed on erythrocytes of all individuals of blood group A, B, or O, respectively. The common denominator is the Fucα1.2-glycan presented by all three ABH antigens, because the bone marrow (from where the erythrocytes originate) express the common H-(fucosyl)transferase. Lack of fucosylated ABH antigens on erythrocytes in circulation (Bombay phenotype) is exceedingly rare. The ABH antigens are also expressed along the oro-gastro-intestinal (GI) mucosal lining in individuals of "positive secretor status" (secretor phenotype, Se) \[[@ppat-0040002-b011],[@ppat-0040002-b012]\]. This is because Se individuals express the Secretor-(fucosyl)transferase, which is the enzyme that produces the Fucα1.2-glycan structure, the hallmark of ABH antigens in saliva, and gastrointestinal mucus secretions and epithelium (see [Figure 1](#ppat-0040002-g001){ref-type="fig"}A for bg antigens). Due to the mucosal secretor-transferase, gastrointestinal epithelia of secretors express blood group O antigens \[Lewis b (Le^b^) and H antigens\], which can be extended by a GalNAc- or Gal-residue into bg A or B antigens, respectively \[[@ppat-0040002-b012]\] ([Figure 1](#ppat-0040002-g001){ref-type="fig"}). In contrast, individuals of non-secretor phenotype, Se^0^, lack the secretor-transferase altogether, and make the shorter Lewis a antigen (Le^a^) \[[@ppat-0040002-b013]\] ([Figure 1](#ppat-0040002-g001){ref-type="fig"}). A third and most recently described human secretor phenotype, the weak-secretor phenotype, Se^w^, is characterized by expression of both Le^a^ and Le^b^ antigens. The composite of Le^a^ and Le^b^ antigens is the consequence of a weak (mutated) form of the secretor transferase \[[@ppat-0040002-b011]\] ([Figure 1](#ppat-0040002-g001){ref-type="fig"}B and [Figure 1](#ppat-0040002-g001){ref-type="fig"}C).

![Fucosylated and Sialylated Blood Group (bg) Antigens and Associated Secretor Phenotypes\
(A) The α1.2-fucosylated (in red) H and Le^b^ antigens define bg O. Bg A and B antigens present additional GalNAc or Gal residues (blue), respectively. Le^y^ and Le^b^ are both difucosylated. SLe^a^ and sLe^x^ are sialylated Lewis antigens (in pink).\
(B) Synthesis pathways for bg antigens with corresponding Se phenotypes: Le^a^ is found in Se^0^ individuals, whereas Se^w^ individuals carry a mix of mucosal Le^a^ and Le^b^. Le^a^ is formed when the Se-transferase is inactive or weak, because Le^a^ is a "dead-end" and is not extended further. During inflammation and infection, sialyl-transferases are expressed and carbohydrate core chains become sialylated in competition with Se-fucosyltransferase.\
(C) The presence of ABH and Le^a^ antigens in salivary, milk, and GI tract secretions identifies individuals of Se, Se^0^, or Se^w^ phenotype.\
(D) In Se^w^ subjects, α1.2fucosylation is hampered by an enzymatically weak Se-transferase, whereas Se^0^ individuals lack Se-transferase activity.](ppat.0040002.g001){#ppat-0040002-g001}

A protective mucus layer comprised of mucin glycoproteins carrying multitudes of carbohydrate structures covers the mucosal surfaces. This glyco-mucus layer exhibits rapid turnover and is shed into the GI tract lumen together with scavenged and aggregated secretions, desquamated cells, and microorganisms. Mucins from both humans and Rhesus monkeys efficiently bind H. pylori via fucosylated carbohydrates \[[@ppat-0040002-b014],[@ppat-0040002-b015]\]. Thus, fucosylated host secretions such as mucins, saliva, and milk, inhibit adherence of H. pylori and other microbial pathogens to the mucosal cell surfaces \[[@ppat-0040002-b016]--[@ppat-0040002-b018]\].

A majority of Caucasians (80%) are secretors, whereas 20% of them are non-secretors, and weak-secretor individuals are rare or not yet discovered. In contrast, weak-secretor individuals are common among Chinese, Japanese, Polynesians, Australian aborigines, and African-Americans \[[@ppat-0040002-b011]\]. The skewed prevalence in secretor phenotypes suggests selection in response to specific types of infections or other environmental conditions. Indeed, Se^0^ individuals are more at risk for urinary tract infections \[[@ppat-0040002-b019],[@ppat-0040002-b020]\]; Se^0^ subjects also express higher inflammatory reactivity and sialylated host antigens to H. pylori infection, which may explain the higher prevalence of peptic ulcer disease observed in those subjects \[[@ppat-0040002-b021]--[@ppat-0040002-b023]\]. In contrast, Se^0^ individuals are less likely to develop Norwalk virus--induced acute gastroenteritis due to the lack of mucosal Se-dependent ABH antigens that mediate mucosal adherence of virus particles in Se subjects \[[@ppat-0040002-b024]\].

Here, the dynamics of mucosal responses to H. pylori infection was studied in Rhesus monkeys because this animal is subject to natural H. pylori infection and exhibits human-like patterns of gastric glycosylation \[[@ppat-0040002-b015],[@ppat-0040002-b025]--[@ppat-0040002-b027]\]. Furthermore, the complete description of the macaque genome is available for this important primate model \[[@ppat-0040002-b028]\]. After determining the ABO blood groups and secretor phenotypes of 41 Rhesus monkeys, we inoculated virulent H. pylori strains to representative secretor groups. During the persistent H. pylori infection that ensued, gastric mucosal fucosylation transiently decreased and sialylation reciprocally increased. *In vivo H. pylori* density, inflammation, and *in vitro* adherence of H. pylori to sialylated antigens were all lower among weak-secretors (the common Rhesus monkey phenotype) compared to regular secretors.

We propose that mucosal glycosylation on GI cell surfaces and secretions as determined by secretor status together influence the course of H. pylori infection as part of the primate innate immunity.

Results {#s2}
=======

Rhesus Monkey ABO Blood Groups and Secretor Phenotypes {#s2a}
------------------------------------------------------

Immunostaining of gastric biopsies from 41 Rhesus monkeys without H. pylori infection demonstrated that 28 animals (68%) were of bg B and 13 (32%) were of bg AB. Thus, mucosal bg B antigen was expressed in all 41 monkeys. The positive immunostaining of bg B and A antigens in the gastric epithelium also demonstrates that all animals were secretors (Se) of ABH-antigens and, hence, that non-secretors (Se^0^ that lack ABH antigens in the GI mucosal lining) were not represented in this large group of monkeys ([Figure 1](#ppat-0040002-g001){ref-type="fig"}). In addition, 34/41 (83%) animals expressed both Le^a^ and Le^b^, an antigen combination that, in humans, is regarded as the characteristics of the weak-secretor phenotype (Se^w^). Only seven monkeys did not express mucosal Le^a^ and they were identified as regular Se. Thus, Se^w^ status with the weak form of secretor transferase appears to be the predominant secretor phenotype in the Rhesus monkey.

Secretor Phenotype Affects H. pylori Infection Density and Gastritis {#s2b}
--------------------------------------------------------------------

A total of ten animals, 3/7 Se (bg B) and 7/34 Se^w^ (bg B, Le^a+^ Le^b+^) animals, were selected for H. pylori inoculation experiments, and two virulent CagA and VacA positive H. pylori strains became predominant in most animals after a few months \[[@ppat-0040002-b029]\]. We determined that these two strains could bind both ABH and sLe^a/x^ antigens (see [Materials and Methods](#s4){ref-type="sec"}). Persistent high-grade infection was observed in 9/10 monkeys and only animal 86D02 (Se^w^) demonstrated low-grade infection (H. pylori score of 1, gastritis score ranging from 1 to 2, but negative cultures, [Table S1](#ppat-0040002-st001){ref-type="supplementary-material"}).

H. pylori infection and associated gastritis developed similarly in the antrum ([Figure 2](#ppat-0040002-g002){ref-type="fig"}A and [2](#ppat-0040002-g002){ref-type="fig"}C) and in the corpus ([Figure S2](#ppat-0040002-sg002){ref-type="supplementary-material"}A and [S2](#ppat-0040002-sg002){ref-type="supplementary-material"}C) starting at day 7 after infection. In both regions of the stomach, *H. pylori in vivo* density score was 2-fold higher in Se than in the dominant Se^w^ phenotype from 4 to 10 months after inoculation ([Figures 2](#ppat-0040002-g002){ref-type="fig"}B and [S2](#ppat-0040002-sg002){ref-type="supplementary-material"}B, *P* \<0.05). Consistent with the higher infection load**,** secretors had increased levels of gastritis compared to weak-secretors but the difference was significant only in the corpus ([Figures 2](#ppat-0040002-g002){ref-type="fig"}D and [S2](#ppat-0040002-sg002){ref-type="supplementary-material"}D). Interestingly, corpus gastritis scores increased significantly compared to pre-inoculation levels only in Se monkeys but not in Se^w^ animals ([Figure S2](#ppat-0040002-sg002){ref-type="supplementary-material"}D). Finally, H. pylori infection density and gastritis were strongly correlated ([Table 1](#ppat-0040002-t001){ref-type="table"}A).

![Infection Density, Gastritis, and Mucosal Sialylation in Proximal Stomach (Antrum), in Response to H. pylori Infection (Means ± SEM)\
The figure illustrates the time course of H. pylori infection density scores in biopsies from the ten monkeys (A) and in three Se and seven Se^w^ individuals following inoculation (B). Also illustrated is the time course of gastritis scores in biopsies from the ten monkeys (C) and from the three Se and seven Se^w^ individuals following inoculation (D). Finally, the mean percentages of sLe^a^ positive (E) and sLe^x^ positive surface epithelium (F) are shown in the ten monkeys following inoculation. \* Illustrates significant (*P* \<0.05) difference from pre-inoculation value and \# illustrates significant (*P* \<0.05) difference between Se and Se^w^.](ppat.0040002.g002){#ppat-0040002-g002}

###### 

Correlation Coefficients for Parameters That Were Found to be Statistically Significant (See "Statistics" in Materials and Methods and in [Protocol S1](#ppat-0040002-sd001){ref-type="supplementary-material"})

![](ppat.0040002.t001)

Time-Dependent Suppression of Fucosylated Blood Group Antigens during Infection {#s2c}
-------------------------------------------------------------------------------

In all seven Se^w^ monkeys, both Le^b^ and Le^a^ antigens were expressed in surface epithelium before experimental infection ([Figure 3](#ppat-0040002-g003){ref-type="fig"}A). At 1--4 weeks after inoculation, Le^b^ ([Figure 3](#ppat-0040002-g003){ref-type="fig"}B) and/or Le^a^ expression (data not shown) transiently decreased in 5/7 monkeys**.** However, by 2--4 months, expression of Le^b^/Le^a^ returned to pre-inoculation levels or higher ([Figure 3](#ppat-0040002-g003){ref-type="fig"}C). Similarly, the fucosylated Lewis y (Le^y^) antigen expressed in the gastric glands of both Se and Se^w^ non-infected animals initially decreased in response to inoculation, and then returned to baseline in 8/10 monkeys (data not shown). Thus, H. pylori infection causes general suppression of fucosylation in the gastric mucosa, as reflected by the alterations in the different Le^a^, Le^b^, and Le^y^ antigens (this series of fucosylated Lewis antigens are described in [Figure 1](#ppat-0040002-g001){ref-type="fig"}A).

![Dynamic Reciprocity in Expression of Fucosylated and Sialylated Antigens in Gastric Mucosa during H. pylori Infection\
Le^b^ expression in monkey 8PZ at pre-inoculation (A), 1 week post-inoculation (B), and 2 months post inoculation (C). Thus, gastric mucosal fucosylation was initially strong (A), decreased from 1 to 4 weeks post-inoculation (B), returned to basal level at 2 months (C), and stayed at basal level until 10 months (not shown). The figure also illustrates the expression of sialyl-Le^a^ (D, E, and F) and sialyl-Le^x^ (G, H, and I) in monkey 8PZ at pre-inoculation (D and G), 2 months (E and H), and 10 months post-inoculation (F and I). Thus, gastric mucosal sialylation increased during early infection (not shown), peaked at 2 months (E and H), and returned to pre-inoculation levels at 10 months post-inoculation (F and I).](ppat.0040002.g003){#ppat-0040002-g003}

Expression of Sialylated Lewis Antigens in Dynamic Response to Infection and Gastritis {#s2d}
--------------------------------------------------------------------------------------

The mean percentage of sialyl-Lewis a (sLe^a^) and sialyl-Lewis x (sLe^x^) positive surface epithelial cells rapidly increased in all monkeys with established H. pylori infection ([Figure 2](#ppat-0040002-g002){ref-type="fig"}E and [2](#ppat-0040002-g002){ref-type="fig"}F in antrum and in [Figure S2](#ppat-0040002-sg002){ref-type="supplementary-material"}E and [S2](#ppat-0040002-sg002){ref-type="supplementary-material"}F in corpus). Sialyl expression is also illustrated in [Figure 3](#ppat-0040002-g003){ref-type="fig"}D--[3](#ppat-0040002-g003){ref-type="fig"}I. Expression of sLe^a^ was stronger than that of sLe^x^, and the percentage of sLe^a^ positive cells rapidly increased 4-fold within a week of inoculation. Thus, a majority of surface epithelial cells (60%) express strong sLe^a^ at 2 months both in antrum and corpus ([Figures 2](#ppat-0040002-g002){ref-type="fig"}E and [S2](#ppat-0040002-sg002){ref-type="supplementary-material"}E). Similarly, expression of sLe^x^ was strongest at 2 months ([Figure 2](#ppat-0040002-g002){ref-type="fig"}F). Expression of sialylated antigens later decreased in seven monkeys ([Figures 2](#ppat-0040002-g002){ref-type="fig"}E and [S2](#ppat-0040002-sg002){ref-type="supplementary-material"}E and also illustrated in [Figure 3](#ppat-0040002-g003){ref-type="fig"}F and [3](#ppat-0040002-g003){ref-type="fig"}I). Importantly, sLe^a^ and sLe^x^ expression in surface epithelium of antrum correlated with both H. pylori density and gastritis scores (see [Table 1](#ppat-0040002-t001){ref-type="table"}B).

Stable Expression of Gastric Type of Mucin Core Proteins during Infection {#s2e}
-------------------------------------------------------------------------

The observed shifts in glycosylation were not due to pre-dysplastic alterations of the gastric mucosa such as intestinal metaplasia, because the spatial distribution of expression patterns for the two common gastric mucins MUC5AC and MUC6 ([Figure S3](#ppat-0040002-sg003){ref-type="supplementary-material"}) were unchanged during the 10-month period of experimental infection, with no aberrant MUC2 or atypical sulfo-mucins being detected (data not shown).

The *In Vitro* Adherence Patterns Revealed by BabA and SabA Mutants Paralleled the Changes in Mucosal Fucosylation and Sialylation Observed during Infection *In Vivo* {#s2f}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------

The significant correlation between H. pylori density and gastritis and the similarity in time course ([Figures 2](#ppat-0040002-g002){ref-type="fig"}A, [2](#ppat-0040002-g002){ref-type="fig"}C, [S2](#ppat-0040002-sg002){ref-type="supplementary-material"}A, and [S2](#ppat-0040002-sg002){ref-type="supplementary-material"}C) suggest that the higher level of mucosal inflammation is a consequence of the higher infection load. Because of the exclusive binding properties of BabA (for fucosylated antigens) and SabA (for sialylated antigens) mediated binding properties \[[@ppat-0040002-b003],[@ppat-0040002-b030]\], H. pylori mutants were applied as lectin-like tools in an *in vitro* adherence assay to functionally map detailed shifts specific for secretor-dependent mucosal fucosylation and sialylation induced by H. pylori infection and the associated inflammatory responses. The Δ*sabA* (BabA+) mutant bound fucosylated, secretor-dependent ABH/Le^b^ antigens (but not the shorter Le^a^ or sialylated antigens), whereas the Δ*babA* (SabA+) mutant bound inflammation-associated sialylated (but not fucosylated) antigens \[[@ppat-0040002-b002],[@ppat-0040002-b005],[@ppat-0040002-b031]\]. Representative adherence patterns of binding to Rhesus monkey biopsies by the Δ*sabA* (BabA+) and the Δ*babA* (SabA+) mutants are shown in [Figure S1](#ppat-0040002-sg001){ref-type="supplementary-material"}. In histo-tissue sections of gastric mucosa, the Δ*sabA* (BabA+) mutant binds to the foveolar epithelium cell surfaces and intra cellular mucins and, in addition, to the secreted fucosylated mucus layer. These binding tests demonstrate that BabA positive bacteria co-localize with the MUC5AC mucin (compare [Figure S3](#ppat-0040002-sg003){ref-type="supplementary-material"}A and [S3](#ppat-0040002-sg003){ref-type="supplementary-material"}C). By comparison, the Δ*babA* (SabA+) mutant does not bind to the surface epithelium of non-infected Rhesus monkey gastric mucosa, and SabA-mediated binding instead colocalizes with the sialylated MUC6 mucin expressed in the deeper located glandular region (compare [Figures S3](#ppat-0040002-sg003){ref-type="supplementary-material"}B and [S3](#ppat-0040002-sg003){ref-type="supplementary-material"}D). However, when the mucosa during infection has responded with expression of inflammation-associated antigens, the Δ*babA* (SabA+) mutant binds to the sialylated foveolar epithelium and mucus layer (illustrated in [Figure S1](#ppat-0040002-sg001){ref-type="supplementary-material"}).

Importantly, *in vivo*, H. pylori binds to the intact apical cell surfaces and secreted extracellular mucins in mucus, whereas by the *in vitro* adherence assay and use of histo-tissue sections, the H. pylori bacterial cells also bind to intracellular mucins that have been exposed by histo sectioning of the mucosal cells and tissue. Thus, the *in vitro* adherence method provides an unique opportunity to investigate time-dependent changes in secretor-dependent mucosal glycosylation that occurs during H. pylori infection, i.e., using small pinch biopsies collected at regular intervals during an extended study period and without sacrificing the animals. In the basal state, the BabA-positive Δ*sabA* mutant adhered *in vitro* to the non-inflamed, non-infected gastric mucosa of all ten Rhesus monkeys (see [Figures 4](#ppat-0040002-g004){ref-type="fig"}A and [S3](#ppat-0040002-sg003){ref-type="supplementary-material"}C), in accordance with the mucosal expression of secretor-dependent bg B antigen in all monkeys. Following H. pylori inoculation, the dynamics of glycosylation and inflammation were tightly correlated (see [Table 1](#ppat-0040002-t001){ref-type="table"}), as revealed by the rapid and transient decrease in BabA-mediated *in vitro* adherence that paralleled the expression patterns of fucosylated antigens (Compare [Figure 4](#ppat-0040002-g004){ref-type="fig"}A with [Figure 3](#ppat-0040002-g003){ref-type="fig"}A--[3](#ppat-0040002-g003){ref-type="fig"}C).

![Time Course of Gastric Mucosal Fucosylation and Sialylation following Inoculation of H. pylori to Rhesus Monkeys as Determined by the *In Vitro* Adherence Assay\
The figure illustrates that inoculation of H. pylori induces a strong, time-dependent, increase in mucosal fucosylation and a concurrent suppression of inflammation-associated sialylation in Se monkeys (**□**), whereas changes are milder in individuals of Se^w^ phenotype (). The changes in the glycosylation pattern were followed by use of *in vitro* adherence analyses and fluorescent H. pylori bacterial cells as glycosylation-specific lectin tools. Because the H. pylori Δ*sabA* (BabA+) and Δ*babA* (SabA+) mutants bind primarily to fucosylated and sialylated structures, respectively, the time-dependent changes measured in terms of *in vitro* adherence reflect parallel changes in surface epithelium fucosylation and sialylation. In vitro adherence mediated by the BabA adhesin (in [Figure S1](#ppat-0040002-sg001){ref-type="supplementary-material"}) identifies the mucosal expression patterns of secretor-dependent fucosylation of ABH and Le^b^ antigens (A), whereas adherence mediated by the SabA adhesin reveals mucosal sialylation (B). Importantly, only *in vitro* adherence to surface epithelium is shown, because it is fucosylated by the Se-transferase. From each of 120 biopsies, ten gastric pit regions were acquired for digital analysis (i.e., a total of 1,200 mucosal zones were analyzed) \[[@ppat-0040002-b031]\]. \# Illustrates significant (*P* \<0.05) differences between Se and Se^w^ subjects at the corresponding times.](ppat.0040002.g004){#ppat-0040002-g004}

Expression of secretor-dependent mucosal fucosylation involved in H. pylori adhesion remained strong and robust throughout the 10-month observation period in Se^w^ subjects compared to the rapid initial decrease in fucosylation in Se individuals, as revealed by BabA-mediated *in vitro* adherence to fucosylated bg antigens ([Figure 4](#ppat-0040002-g004){ref-type="fig"}A). In addition, BabA-mediated *in vitro* adherence to fucosylated mucosa was 1.7 times higher in Se^w^ than in Se monkeys (*P* \<0.001) and inversely correlated with *in vivo H. pylori* density, gastritis, and sLe^x^ expression (see [Tables 1](#ppat-0040002-t001){ref-type="table"}D and [1](#ppat-0040002-t001){ref-type="table"}E, respectively). Thus, Se^w^ with strong and robust expression of gastric fucosylation have both lower *H. pylori* infection density and less gastritis compared to Se individuals ([Figures 4](#ppat-0040002-g004){ref-type="fig"}A, [2](#ppat-0040002-g002){ref-type="fig"}B, and [2](#ppat-0040002-g002){ref-type="fig"}D).

The strong fucosylation in Se^w^ monkeys, as revealed by the robust BabA-mediated *in vitro* adherence, reflects the high density of fucosylated mucins in the Se^w^ gastric mucosa. Indeed, gastric mucins purified from healthy, non-infected Rhesus monkey bind H. pylori primarily via fucosylated structures ([Figure S3](#ppat-0040002-sg003){ref-type="supplementary-material"}E), similarly to human mucins binding to H. pylori \[[@ppat-0040002-b004],[@ppat-0040002-b014]\].

In contrast to BabA-mediated adherence, *in vitro* adherence to sialylated glycoconjugates by the SabA positive Δ*babA* mutant was absent in the surface epithelium of healthy, uninfected mucosa. However, SabA-mediated adherence rapidly increased in response to inoculation, thus demonstrating induction of mucosal sialylation. SabA-mediated *in vitro* adherence to the surface epithelium correlated with both *in vivo H. pylori* density and gastritis ([Table 1](#ppat-0040002-t001){ref-type="table"}D) and with expression of the inflammation-associated sLe^x^ and sLe^a^ antigens ([Table 1](#ppat-0040002-t001){ref-type="table"}E). Furthermore, SabA-mediated *in vitro* adherence to sialylated glycoconjugates was 1.9-fold higher in Se than in Se^w^ monkeys ([Figure 4](#ppat-0040002-g004){ref-type="fig"}B). The rapid induction of SabA-mediated binding to the sialylated surface epithelium of the gastric mucosa ([Figure 4](#ppat-0040002-g004){ref-type="fig"}B) demonstrates that Se monkeys react with stronger inflammatory response and higher recruitment of inflammatory cells, i.e., gastritis, whereas the Se^w^ animals with low grade infection and inflammation provides sparse mucosal sialylation and only modest recruitment of inflammatory cells. Fucosylation and sialylation levels follow opposite dynamics during the full 10-month observation period (fucosylation in [Figures 4](#ppat-0040002-g004){ref-type="fig"}A and [3](#ppat-0040002-g003){ref-type="fig"}A--[3](#ppat-0040002-g003){ref-type="fig"}C; sialylation in [Figures 4](#ppat-0040002-g004){ref-type="fig"}B and [3](#ppat-0040002-g003){ref-type="fig"}D--[3](#ppat-0040002-g003){ref-type="fig"}I; [Table 1](#ppat-0040002-t001){ref-type="table"}C). Thus, Se^w^ individuals are more robust in mucosal fucosylation and balanced in sialylation, which confers lower inflammatory level, lower gastritis, and lower H. pylori infection density as compared to Se individuals ([Figures 2](#ppat-0040002-g002){ref-type="fig"}B, [2](#ppat-0040002-g002){ref-type="fig"}D, [S2](#ppat-0040002-sg002){ref-type="supplementary-material"}B, and [S2](#ppat-0040002-sg002){ref-type="supplementary-material"}D).

Discussion {#s3}
==========

The present study demonstrates that Se^w^ individuals have robust mucosal fucosylation and lower mucosal inflammatory and sialylation responses to experimental H. pylori infection. Therefore, Se^w^ monkeys would be expected to better tolerate persistent infections and to be more prevalent in regions with high incidence of this type of infections. Such a selection for specific blood group phenotypes is strongly suggested by our observation that all 41 macaques included in the study express blood group B antigens, especially since the blood group B is the least common worldwide of the ABO phenotypes. Interestingly, the ancestors of most macaques used in the present study originated from Northern India, which is the region with highest worldwide prevalence of bg B phenotype in humans \[[@ppat-0040002-b032],[@ppat-0040002-b033]\]. The recent Rhesus macaque genome annotation revealed that the Indian and Chinese groups diverged some 160,000 years ago \[[@ppat-0040002-b034]\]. Interestingly, all the ABO blood groups are represented among macaques that moved to Southeast Asia/Thailand \[[@ppat-0040002-b035]\], a region in which bg B is lower in humans \[[@ppat-0040002-b032]\]. The human and macaque paralleled demographic selection for high prevalence of Se^w^ and bg B phenotype may result from selection by endemic infectious disease \[[@ppat-0040002-b036]\] as the two species often suffer from the same infectious diseases. Of particular relevance for the Indian subcontinent, bg B individuals are less likely to become infected by Vibrio cholera \[[@ppat-0040002-b037]\]. In addition, phylogenetic analysis suggests that bg B arose several times and independently from bg A, indicating that the genes of these blood group transferases are prone to convergent evolution \[[@ppat-0040002-b038]\].

The ABO blood groups were discovered over a century ago \[[@ppat-0040002-b039]\], chemically described 50 year ago \[[@ppat-0040002-b040],[@ppat-0040002-b041]\], and cloned almost 20 years ago \[[@ppat-0040002-b042]\]. Similarly, the secretor system was described 60 years ago \[[@ppat-0040002-b043]\], blood group antigens were characterized from human intestine over 30 years ago \[[@ppat-0040002-b044]\] and the Se transferase was cloned in 1995 \[[@ppat-0040002-b013]\], but the biological and functional role of the ABO system has remained an enigma \[[@ppat-0040002-b045]\]. Here, we show that secretor phenotype determines the dynamics of mucosal glycosylation in response to H. pylori infection and conditions the nature of the host response. Thus, H. pylori infection is associated with an increase in sialylated mucosal antigens and a concurrent decrease in fucosylated mucosal antigens. The loss of fucosylation during acute H. pylori infection is probably a consequence of the fast induction in expression of inflammation-associated sialyl-transferases and the resulting competition for carbohydrate chains by glycosyl (sialyl and fucosyl) transferases ([Figure 1](#ppat-0040002-g001){ref-type="fig"}B). Competition between fucosyl- and sialyl-transferases for the same carbohydrate core chains was demonstrated by competition experiments where di-saccharides suppressed both sialylation and formation of selectin (endothelial cell adhesion) ligands on cancer cells \[[@ppat-0040002-b046]\]**.** The present series of results also reveals that, in contrast to Se monkeys, Se^w^ individuals maintain strong and robust expression of fucosylated mucosal ABH antigens during H. pylori infection ([Figure 4](#ppat-0040002-g004){ref-type="fig"}A). Interestingly, intestinal mucosal glycosylation also becomes fucosylated in response to establishment of conventional bacterial flora in gnotobiotic mice \[[@ppat-0040002-b047]\].

The combined results suggest that mucosal fucosylation could be a mixed blessing for *H. pylori.* Indeed, large mucin molecules with fucosylated high-affinity binding sites for BabA could be exploited by H. pylori as *in vivo* binding sites, but they may also act as scouts of the host glycan innate immunity system. Thus, the mucosal fucosylation represents a protective scavenger factor that reduces infection density, especially since H. pylori infection also increases gastric mucus secretion \[[@ppat-0040002-b048]\]. The present demonstration that mucosal fucosylation in response to H. pylori infection reduces bacterial density and associated inflammation and, in particular, impacts on infection in Se^w^ monkeys due to stronger mucosal fucosylation phenotype, strongly suggests that ABH secretor-dependent mucosal glycosylation modulates innate immunity responses and may contribute to variable risk of gastric disease.

Materials and Methods {#s4}
=====================

Experimental animals. {#s4a}
---------------------

The experiments were conducted according to the "Guide for the Care and Use of Laboratory Animals" \[[@ppat-0040002-b049]\]. All procedures involving animals were reviewed and approved by the USUHS animal care and use committee. The ancestors of 37 animals had been captured in India, while four were of mixed Chinese and Indian origin. The localization of Lewis antigens in these monkeys before H. pylori inoculation has been investigated \[[@ppat-0040002-b015]\]. H. pylori and H. heilmannii infection was eradicated in all monkeys 6 months before inoculation \[[@ppat-0040002-b029]\]. The ten male monkeys that were inoculated all originated from India and were 4--13 years old (mean 7.1). F754, 86D02, T4C, 8V5, F436, 82A49, and 8PZ animals were Se^w^, and 86D06, E6C, and 85D08 were Se.

Inoculation strains and cultures. {#s4b}
---------------------------------

Seven low-pass H. pylori strains were cultured, characterized (five were CagA+ and two were CagA-) (see Text S1), and inoculated to monkeys as reported \[[@ppat-0040002-b029]\]. Their binding properties were analyzed by RIA \[[@ppat-0040002-b031]\]: J170, J254, J166, and J258 bound both sLe^x^ and Le^b^, J282 bound Le^b^, and J178 bound sLe^x^.

Immunohistochemistry. {#s4c}
---------------------

Genta-stained sections were used to determine H. pylori density scores and the Sydney system was used to determine gastritis scores \[[@ppat-0040002-b029]\]. Sulfo-mucins were detected with high-iron diamine stain \[[@ppat-0040002-b017]\]. Immunohistochemistry was performed as described \[[@ppat-0040002-b015]\] (see [Text S1](#ppat-0040002-se001){ref-type="supplementary-material"}). For quantitative histochemistry, tissue sections were stained simultaneously. Non-sialylated carbohydrate structures were quantified by visual estimation of intensity, whereas a program by J. Czege, USUHS, was used for sialylated antigens. The surface/foveolar epithelium, lamina propria and glands were separately outlined and the percentage area stained was average from three fields of view.

H. pylori adherence *in vitro.* {#s4d}
-------------------------------

The 17875/Le^b^-mutant was referred to as the Δ*sabA* (BabA^+^) mutant or "BabA-positive mutant", and the isogenic 17875*babA1::kan babA2::cam* deletion mutant was referred to as Δ*babA* (SabA^+^) mutant or "SabA-positive-mutant \[[@ppat-0040002-b002],[@ppat-0040002-b005]\]. In vitro adherence was digitally quantified in a total of 1,200 mucosal zones (120 biopsies, ten pits/biopsy) \[[@ppat-0040002-b031]\] (see [Text S1](#ppat-0040002-se001){ref-type="supplementary-material"}).

Statistics. {#s4e}
-----------

Data are reported as means ± SEM. Changes over time within animals were compared with a mixed-effects ANOVA model corresponding to a repeated-measures ANOVA model with time as a within-subject factor and secretor status as a between-subjects factor. Dunnett\'s post-hoc test was used to compare the average at each time point to the average before inoculation. For each pair of variables, three correlation coefficients were calculated by ANOVA with random effects (see [Protocol S1](#ppat-0040002-sd001){ref-type="supplementary-material"}/Statistics).

Supporting Information {#s5}
======================

###### BabA Adhesin-Mediated Binding of H. pylori to Fucosylated ABO/Le^b^ Blood Group Antigens and SabA Adhesin-Mediated Binding of H. pylori to Sialylated and Inflammation-Associated Antigens in Primate Gastric Mucosa

(3.9 MB DOC)

###### 

Click here for additional data file.

###### Infection Density, Gastritis and Mucosal Sialylation in the Proximal Stomach in Response to H. pylori Infection

(1.0 MB DOC)

###### 

Click here for additional data file.

###### Rhesus Monkey Gastric Mucins

(550 KB DOC)

###### 

Click here for additional data file.

###### Supporting Protocols

1\. Reagents

2\. *H. pylori* culture

3\. Mucin isolation and analyses of blood group glycosylation

4\. *H. pylori* binding to mucins in ELISA

5\. Statistics

(34 KB DOC)

###### 

Click here for additional data file.

###### Individual Values of Gastritis Scores, *H. pylori In Vivo* Density, and Antral and Body sLe^x^ and sLe^a^ Staining for Antrum and Body, and Antral Mucosal Fucosylation and Sialylation Patterns Revealed by *In Vitro* Adherence Mediated by BabA and SabA, Respectively

(266 KB DOC)

###### 

Click here for additional data file.

###### Supporting References

(46 KB DOC)

###### 

Click here for additional data file.
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ABH antigens

:   fucosylated blood group (bg) ABO antigens

BabA

:   blood group antigen--binding adhesin; bg blood group

GI

:   gastro-intestinal

Leb

:   Lewis b

SabA

:   sialic acid--binding adhesin

sLe^x^

:   sialyl-Le^x^

Se

:   secretor phenotype

Se^w^

:   weak-secretor phenotype

Se^0^

:   non-secretor phenotype
